A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI

PHASE2TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2015

Conditions
Colon Cancer
Interventions
DRUG

chemotherapy and GI-4000

"Standard chemotherapy and bevacizumab 40YU GI-4000 prior to initiation of chemotherapy and then intercycle 7 days after each chemotherapy cycle for up to 8 cycles.~maintenance of GI-4000 injection and bevacizumab every 2 weeks"

DRUG

GI-4000

40 YU GI-4000 every 2 weeks Bevacizumab every 2 weeks

Trial Locations (1)

20007

Georgetown University, Washington D.C.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlobeImmune

INDUSTRY

lead

Georgetown University

OTHER